Home NDC 0009-5140 Zyvox
Product NDC 0009-5140
11-digit product format 000095140
Labeler code 0009
Product ID 0009-5140_f61349cd-d7b8-4400-b433-01abcdb0cc99
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name linezolid
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Pharmacia & Upjohn Company LLC
Application NDA021131
Marketing category NDA
Marketing start 2000-04-18
Substance LINEZOLID
Active strength 600 mg/300mL
Pharmacologic classes Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021131-001 ZYVOX LINEZOLID 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 N021131-002 ZYVOX LINEZOLID 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 N021131-003 ZYVOX LINEZOLID 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021131-002 ZYVOX 400MG/200ML (2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2000-04-18 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021131-003 ZYVOX 600MG/300ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2000-04-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021131-001 ZYVOX 200MG/100ML (2MG/ML) SOLUTION / INTRAVENOUS AP RLD 2000-04-18 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Observed Orange Book patent history# Patent history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021131-001 6559305 2021-01-29 Drug substance 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021131-001 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021131-002 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021131-003 6559305*PED 2021-07-29 Pediatric extension 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N021131-001 6559305 2021-01-29 Drug substance 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021131-001 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021131-002 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021131-003 6559305*PED 2021-07-29 Pediatric extension 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-001 6559305 2021-01-29 Drug substance 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-001 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-002 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021131-003 6559305*PED 2021-07-29 Pediatric extension 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021131-001 6559305 2021-01-29 Drug substance 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021131-001 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021131-002 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N021131-003 6559305*PED 2021-07-29 Pediatric extension 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021131-001 6559305 2021-01-29 Drug substance 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021131-001 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021131-002 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021131-003 6559305*PED 2021-07-29 Pediatric extension 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021131-001 6559305 2021-01-29 Drug substance c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021131-001 6559305*PED 2021-07-29 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021131-002 6559305*PED 2021-07-29 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021131-003 6559305 2021-01-29 Drug substance 2003-08-14 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021131-003 6559305*PED 2021-07-29 Pediatric extension c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021131-001 6559305 2021-01-29 Drug substance 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021131-001 6559305*PED 2021-07-29 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021131-002 6559305 2021-01-29 Drug substance 2003-08-14 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021131-002 6559305*PED 2021-07-29 Pediatric extension 3f01610625f2…
Additional Listing Data#
Finished product Yes
Brand name base Zyvox
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LINEZOLID 600 mg/300mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination ISQ9I6J12J Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 8 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 262091 Internal RxNorm lookup 311345 Internal RxNorm lookup 311347 Internal RxNorm lookup 581614 Internal RxNorm lookup 1662278 Internal RxNorm lookup 1662280 Internal RxNorm lookup 1662285 Internal RxNorm lookup 1662286 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0009-5140-01 Zyvox 300 mL in 1 BAG INJECTION, SOLUTION 300 69 0009-5140-04 Zyvox 10 in 1 BOX INJECTION, SOLUTION 10 69
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LINEZOLID ACTIVE INGREDIENT ISQ9I6J12J ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 LINEZOLID ACTIVE MOIETY ISQ9I6J12J ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM INACTIVE INGREDIENT K679OBS311 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 CITRIC ACID MONOHYDRATE INACTIVE INGREDIENT 2968PHW8QP ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 MANNITOL INACTIVE INGREDIENT 3OWL53L36A ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SODIUM CITRATE INACTIVE INGREDIENT 1Q73Q2JULR ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 SUCROSE INACTIVE INGREDIENT C151H8M554 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] 33
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0009-5140 ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) GRANULE, FOR SUSPENSION ZYVOX (LINEZOLID) TABLET, FILM COATED [PHARMACIA & UPJOHN COMPANY LLC] 64 Current NDC, Legacy NDC, 2 package rows 20240726_6e70e63b-bfd5-478d-a8ee-8ba22c9efabd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0009-5140-01 00009514001 300 mL in 1 BAG 300 ml Historical 0009-5140-04 00009514004 10 BAG in 1 BOX (0009-5140-04) / 300 mL in 1 BAG (0009-5140-01) 10 bag 2000-04-18 0000-00-00 No No Current